{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:13:04Z","timestamp":1777615984053,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.bcp.2011.07.096","type":"journal-article","created":{"date-parts":[[2011,8,6]],"date-time":"2011-08-06T16:09:25Z","timestamp":1312646965000},"page":"1781-1791","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Indomethacin induces cellular morphological change and migration via epithelial-mesenchymal transition in A549 human lung cancer cells: A novel cyclooxygenase-inhibition-independent effect"],"prefix":"10.1016","volume":"82","author":[{"given":"Tomoko","family":"Kato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromichi","family":"Fujino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satomi","family":"Oyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuo","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiko","family":"Murayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2011.07.096_bib0005","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nrc1801","article-title":"Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics","volume":"6","author":"Ulrich","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bcp.2011.07.096_bib0010","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S1470-2045(09)70035-X","article-title":"Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement","volume":"10","author":"Cuzick","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bcp.2011.07.096_bib0015","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s10555-007-9096-5","article-title":"Cyclooxygenases, prostanoids, and tumor progression","volume":"26","author":"Wang","year":"2007","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.bcp.2011.07.096_bib0020","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1126\/science.1203543","article-title":"A perspective on cancer cell metastasis","volume":"331","author":"Chaffer","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.bcp.2011.07.096_bib0025","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1038\/sj.bjc.6604662","article-title":"The role of endothelial-to-mesenchymal transition in cancer progression","volume":"99","author":"Potenta","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bcp.2011.07.096_bib0030","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","article-title":"Epithelial-mesenchymal transitions in development and disease","volume":"139","author":"Thiery","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2011.07.096_bib0035","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrc2131","article-title":"Snail ZEB and bHLH factors in tumour progression: an alliance against the epithelial phenotype?","volume":"7","author":"Peinado","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bcp.2011.07.096_bib0040","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0169-5002(01)00471-8","article-title":"The E-cadherin cell-cell adhesion complex and lung cancer invasion, metastasis, and prognosis","volume":"36","author":"Bremnes","year":"2002","journal-title":"Lung Cancer"},{"key":"10.1016\/j.bcp.2011.07.096_bib0045","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1080\/019021490944232","article-title":"Matrix metalloproteinase-2 (MMP-2) and MMP-9 in pulmonary pathology","volume":"31","author":"Chakrabarti","year":"2005","journal-title":"Exp Lung Res"},{"key":"10.1016\/j.bcp.2011.07.096_bib0050","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/jemt.20564","article-title":"Mammalian collagen IV","volume":"71","author":"Khoshnoodi","year":"2008","journal-title":"Microsc Res Tech"},{"key":"10.1016\/j.bcp.2011.07.096_bib0055","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2174\/138920108783497631","article-title":"Matrix metalloproteinases-9\/gelatinase B is a putative therapeutic target of chronic obstructive pulmonary disease and multiple sclerosis","volume":"9","author":"Muroski","year":"2008","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.bcp.2011.07.096_bib0060","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10555-009-9194-7","article-title":"Roles of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer","volume":"28","author":"McConkey","year":"2009","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.bcp.2011.07.096_bib0065","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1196\/annals.1294.016","article-title":"Cadherin switch in tumor progression","volume":"1014","author":"Hazan","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.bcp.2011.07.096_bib0070","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJMct0807960","article-title":"Treatment of non-small-cell lung cancer with erlotinib or gefitinib","volume":"364","author":"Cataldo","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bcp.2011.07.096_bib0075","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/S0305-7372(10)70017-7","article-title":"Maintenance or non-maintenance therapy in the treatment of advanced non-small cell lung cancer: that is the question","volume":"36S3","author":"Galetta","year":"2010","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.bcp.2011.07.096_bib0080","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s11912-003-0077-8","article-title":"Treatment options for brain metastases in patients with non-small-cell lung cancer","volume":"5","author":"Taimur","year":"2003","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.bcp.2011.07.096_bib0085","doi-asserted-by":"crossref","first-page":"S253","DOI":"10.1016\/j.lungcan.2004.07.967","article-title":"Treatment of brain metastases from lung cancer: chemotherapy","volume":"45","author":"Schuette","year":"2004","journal-title":"Lung Cancer"},{"key":"10.1016\/j.bcp.2011.07.096_bib0090","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.3892\/or_00000564","article-title":"Medical management of brain metastases from lung cancer (Review)","volume":"22","author":"Yamanaka","year":"2009","journal-title":"Oncol Rep"},{"key":"10.1016\/j.bcp.2011.07.096_bib0095","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1517\/14728220902915567","article-title":"Targeting the eicosanoid pathway in non-small-cell lung cancer","volume":"13","author":"Horn","year":"2009","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.bcp.2011.07.096_bib0100","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2174\/187152006776930882","article-title":"The potential and rationale for COX-2 inhibitors in lung cancer","volume":"6","author":"Krysan","year":"2006","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1016\/j.bcp.2011.07.096_bib0105","doi-asserted-by":"crossref","first-page":"4266s","DOI":"10.1158\/1078-0432.CCR-040014","article-title":"Cyclooxygenase as a target in lung cancer","volume":"10","author":"Brown","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2011.07.096_bib0110","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/JTO.0b013e31802f1cc5","article-title":"Nonsteroidal anti-inflammaatory drugs and lung cancer risk: a population-based case control study","volume":"2","author":"Wall","year":"2007","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.bcp.2011.07.096_bib0115","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1158\/1055-9965.EPI-06-0172","article-title":"Association between nonsteroidal anti-inflammatory drug use and the incidence of lung cancer in the Iowa women's health study","volume":"15","author":"Hayes","year":"2006","journal-title":"Cancer Epidemol Biomarkers Prev"},{"key":"10.1016\/j.bcp.2011.07.096_bib0120","doi-asserted-by":"crossref","first-page":"29907","DOI":"10.1074\/jbc.M003467200","article-title":"Delayed reversal of shape change in cells expressing FPB prostanoid receptors. Possible role of receptor resensitization","volume":"275","author":"Fujino","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2011.07.096_bib0125","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.bcp.2010.11.001","article-title":"Prostaglandin E2 regulates cellular migration via induction of vascular endothelial growth factor receptor-1 in HCA-7 human colon cancer cells","volume":"81","author":"Fujino","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2011.07.096_bib0130","doi-asserted-by":"crossref","first-page":"48786","DOI":"10.1074\/jbc.M209393200","article-title":"Cellular conditioning and activation of \u03b2-catenin signaling by the FPB prostanoid receptor","volume":"277","author":"Fujino","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2011.07.096_bib0135","doi-asserted-by":"crossref","first-page":"18757","DOI":"10.1073\/pnas.0910218106","article-title":"Microsomal prostaglandin E synthase 1 determines tumor growth in vivo of prostate and lung cancer cells","volume":"106","author":"Hanaka","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2011.07.096_bib0140","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0955-0674(98)80095-1","article-title":"Microtubules and actin filaments: dynamic target for cancer chemotherapy","volume":"10","author":"Jordan","year":"1988","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.bcp.2011.07.096_bib0145","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1742-4658.2010.07919.x","article-title":"Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting","volume":"278","author":"Gialeli","year":"2011","journal-title":"FEBS J"},{"key":"10.1016\/j.bcp.2011.07.096_bib0150","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1073\/pnas.0804543106","article-title":"Endotherial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR","volume":"106","author":"Al-Nedawi","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2011.07.096_bib0155","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0014-5793(01)03118-0","article-title":"Non-steroidal anti-inflammatory drugs inhibit matrix metalloproteinase-2 expression via repression of transcription in lung cancer cells","volume":"508","author":"Pan","year":"2001","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bcp.2011.07.096_bib0160","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1074\/jbc.272.6.3406","article-title":"Peroxisome proliferator-activated receptors \u03b1 and \u03b3 are activated by indomethacin and other non-steroidal anti-inflammatory drugs","volume":"272","author":"Lehmann","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2011.07.096_bib0165","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1096\/fj.02-1075fje","article-title":"PPAR\u03b3 ligands induce prostaglandin production in vascular smooth muscle cells: indomethacin acts as a peroxisome prolifertor-activated receptor-\u03b3 antagonist","volume":"17","author":"Bishop-Bailey","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.bcp.2011.07.096_bib0170","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.abb.2009.11.025","article-title":"Decrease in uptake of arachidonic acid by indomethacin in LS174T human colon cancer cells; a novel cyclooxygenase-2-inhibition-independent effect","volume":"494","author":"Orido","year":"2010","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.bcp.2011.07.096_bib0175","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/sj.onc.1206885","article-title":"Peroxisome proliferator-activated receptor-\u03b3 activation inhibits tumor progression in non-small-cell lung cancer","volume":"23","author":"Keshamouni","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2011.07.096_bib0180","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0006-2952(00)00578-5","article-title":"Comparative effects of indomethacin on cell proliferation and cell cycle progression in tumor cells grown in vitro and in vivo","volume":"61","author":"Eli","year":"2001","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2011.07.096_bib0185","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1158\/1535-7163.MCT-09-0638","article-title":"Proanthocyanidins inhibit in vitro and in vivo growth of human non-small cell lung cancer cells by inhibiting the prostaglanidn E2 and prostaglandin E2 receptors","volume":"9","author":"Sharma","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bcp.2011.07.096_bib0190","doi-asserted-by":"crossref","first-page":"L715","DOI":"10.1152\/ajplung.00361.2009","article-title":"Epitherial repair mechanisms in the lung","volume":"298","author":"Crosby","year":"2010","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.bcp.2011.07.096_bib0195","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.lungcan.2011.01.019","article-title":"Molecular cross-regulation between PPAR-\u03b3 and other signaling pathways: implications for lung cancer therapy","volume":"72","author":"Reka","year":"2011","journal-title":"Lung Cancer"},{"key":"10.1016\/j.bcp.2011.07.096_bib0200","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1158\/1535-7163.MCT-10-0570","article-title":"Peroxisome proliferator-activated receptor-\u03b3 activation inhibits tumor metastasis by antagonizing Smad3-mediated epithelial-mesenchymal transition","volume":"9","author":"Reka","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bcp.2011.07.096_bib0205","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/34178","article-title":"The peroxisome proliferator-activated receptor-\u03b3 is a negative regulator of macrophage activation","volume":"391","author":"Ricote","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2011.07.096_bib0210","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0014-5793(99)00268-9","article-title":"PPAR\u03b3 activators down-regulate the expression of PPAR(in 3T3-L1 adipocytes","volume":"447","author":"Camp","year":"1999","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bcp.2011.07.096_bib0215","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.canlet.2008.08.008","article-title":"PPAR\u03b3-independent antitumor effects of thiazolidinediones","volume":"276","author":"Wei","year":"2009","journal-title":"Cancer Lett"},{"key":"10.1016\/j.bcp.2011.07.096_bib0220","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1124\/mol.61.1.7","article-title":"Diclofenac antagonizes peroxisome proliferator-activated receptor-\u03b3 signaling","volume":"61","author":"Adamson","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2011.07.096_bib0225","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1124\/mol.62.5.1207","article-title":"Peroxisome proliferator-activated receptor-\u03b3 is a target of nonsteroidal anti-inflammatory drugs mediating cyclooxygenase-independent inhibition of lung cancer cell growth","volume":"62","author":"Wick","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2011.07.096_bib0230","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.bbrc.2007.05.145","article-title":"Indomethacin decreases EP2 prostanoid receptor expression in colon cancer cells","volume":"359","author":"Fujino","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bcp.2011.07.096_bib0235","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1254\/jphs.08167SC","article-title":"Indomethacin decreases arachidonic acid uptake in HCA-7 human colon cancer cells","volume":"108","author":"Orido","year":"2008","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.bcp.2011.07.096_bib0240","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1593\/neo.06187","article-title":"Mechanisms of indomethacin-induced alterations in the choline phospholipids metabolism of brest cancer cells","volume":"8","author":"Glunde","year":"2006","journal-title":"Neoplasia"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295211006137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295211006137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T12:54:32Z","timestamp":1757768072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295211006137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":48,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0006295211006137"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2011.07.096","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Indomethacin induces cellular morphological change and migration via epithelial-mesenchymal transition in A549 human lung cancer cells: A novel cyclooxygenase-inhibition-independent effect","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2011.07.096","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}